Melissa Moore

A randomized controlled trial of a wearable technology-based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial

Brigid M Lynch, Nga H Nguyen, Melissa M Moore, Marina M Reeves, Dori E Rosenberg, Terry Boyle, Jeff K Vallance, Shakira Milton, Christine M Friedenreich, Dallas R English

Journal article  |  2019  |  Cancer

BACKGROUND: The benefits of an active lifestyle after a breast cancer diagnosis are well recognized, but the majority of survivors..

Study design and methods for the ACTIVity And TEchnology (ACTIVATE) trial

Brigid M Lynch, Nga H Nguyen, Marina M Reeves, Melissa M Moore, Dori E Rosenberg, Michael J Wheeler, Terry Boyle, Jeff K Vallance, Christine M Friedenreich, Dallas R English

Journal article  |  2018  |  Contemporary Clinical Trials

A qualitative evaluation of breast cancer survivors' acceptance of and preferences for consumer wearable technology activity trackers

Nga H Nguyen, Nyssa T Hadgraft, Melissa M Moore, Dori E Rosenberg, Chris Lynch, Marina M Reeves, Brigid M Lynch

Journal article  |  2017  |  Supportive Care in Cancer

EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma

Timothy D Clay, Prudence A Russell, Hongdo Do, Vijaya Sundararajan, Matthew Conron, Gavin M Wright, Benjamin Solomon, Alexander Dobrovic, Sue-Anne McLachlan, Melissa M Moore

Journal article  |  2017  |  Medical Oncology

Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations

TD Clay, PA Russell, H Do, V Sundararajan, M Conron, GM Wright, A Dobrovic, MM Moore, SA McLachlan

Journal article  |  2016  |  Pathology

The Clinical Relevance of Pathologic Subtypes in Metastatic Lung Adenocarcinoma

Timothy D Clay, Hongdo Do, Vijaya Sundararajan, Melissa M Moore, Matthew Conron, Gavin M Wright, Sue-Anne McLachlan, Alexander Dobrovic, Prudence A Russell

Journal article  |  2014  |  Journal of Thoracic Oncology

EGFR gene copy number alterations are not a useful screening tool for predicting EGFR mutation status in lung adenocarcinoma

Prudence A Russell, Yong Yu, Hongdo Do, Timothy D Clay, Melissa M Moore, Gavin M Wright, Matthew Conron, Zoe Wainer, Alexander Dobrovic, Sue-Anne McLachlan

Journal article  |  2014  |  Pathology